טוען...
Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma
Background: Anaplastic thyroid carcinoma (ATC) remains one of the most challenging malignancies to treat in the modern era. Most patients present with or develop recurrent/metastatic incurable disease with poor response rates to conventional chemotherapy, and life expectancy is short. Next-generatio...
שמור ב:
| הוצא לאור ב: | Thyroid |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Mary Ann Liebert, Inc., publishers
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7482117/ https://ncbi.nlm.nih.gov/pubmed/32292131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2019.0477 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|